Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer.

Chia-Hsun ChuTzu-Hsuan ChiuChin-Chou WangWen-Chen ChangAllen Chung-Cheng HuangChien-Ying LiuChih-Liang WangHo-Wen KoFu-Tsai ChungPing-Chih HsuYi-Ke GuoAllen Chung-Cheng HuangCheng-Ta Yang

Published in: Thoracic cancer (2020)

Durvalumab consolidation treatment in real-world patients showed substantial efficacy and the correlation with the NLR level warrants further investigation.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
squamous cell carcinoma
radiation therapy